ALGS vs IT · rev $3.6M vs P/E 16, rev $6.27B
Aligos Therapeutics Inc (ALGS) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported ALGS revenue for 2024-12-31 was $3.6M. Net income was -$131.2M. Revenue was down 41.7% from 2023-12-31 to 2024-12-31. ALGS currently screens at market cap $44.1M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
ALGS currently screens at market cap $44.1M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the ALGS and IT stock pages for the full models.
Not investment advice.